Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by

Journal Scan / Research · July 31, 2023

Bone Marrow Mesenchymal Stem Cell–Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19

Chest

 

Additional Info

Disclosure statements are available on the authors' profiles:

Chest
Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure from COVID-19: A Randomized Placebo Controlled Dosing Clinical Trial
Chest 2023 Jun 23;[EPub Ahead of Print], AL Lightner, V Sengupta, S Qian, JT Ransom, S Suzuki, DJ Park, TI Melson, BP Williams, JJ Walsh, M Awili

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading